Capacity
AbbVie pours $223M into building out its biologics capacity in Singapore
Biological Factors, expansion, AbbVie, Capacity, Investments, Manufacture, Singapore
Actionable Insights Powered by AI
Biological Factors, expansion, AbbVie, Capacity, Investments, Manufacture, Singapore